Abstract
Purpose: The aim of this study was to explore the presence of the chemokines CCL22 and CCL17 in malignant pleural effusion, and the chemoattractant activity of these chemokines on CD4-positive CD25-positive Foxp3-positive regulatory T cells infiltrating into the pleural space. Experimental Design: The concentrations of CCL22 and CCL17 in both pleural effusions and sera from 33 patients with lung cancer were determined. Flow cytometry was done to determine T lymphocyte subsets in cell pellets of pleural effusion. Pleural cells were analyzed for the expression of CCL22 and CCL17. The chemoattractant activity of CCL22 for regulatory T cells in vitro and in vivo was also observed. Results: The concentration of CCL22 in malignant pleural effusion was significantly higher than that in the corresponding serum. Pleural fluid from lung cancer patients was chemotactic for regulatory T cells, and this activity was partly blocked by an anti-CCL22, but not by an anti-CCL17 antibody. Intrapleural administration of CCL22 of patients produced a marked progressive influx of regulatory T cells into pleural space. Conclusions: Compared with serum, CCL22 seemed to be increased in malignant pleural effusion, and could directly induce regulatory T cell infiltration into the pleural space in patients with malignant effusion. © 2009 American Association for Cancer Research.
Cite
CITATION STYLE
Qin, X. J., Shi, H. Z., Deng, J. M., Liang, Q. L., Jiang, J., & Ye, Z. J. (2009). CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion. Clinical Cancer Research, 15(7), 2231–2237. https://doi.org/10.1158/1078-0432.CCR-08-2641
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.